STXBP5 and neoplasm: Notably, Ham et al. found that both ginsenoside Rg3 and Korean red ginseng extracts were capable of epigenetically regulating the expression of tumor-related RFX3-AS1 and STXBP5-AS1 [22], therefore providing experimental evidences in support of the targetability of STXBP5-AS1 by traditional Chinese medicine.